Cefditoren
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| Clinical data | |
| Trade names | Spectracef |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a605003 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 104145-95-1 |
| ATC code | J01DD16 |
| PubChem | CID 9870843 |
| DrugBank | DB01066 |
| ChemSpider | 8046534 |
| UNII | 81QS09V3YW |
| KEGG | D07639 |
| ChEBI | CHEBI:59343 |
| Chemical data | |
| Formula | C19H18N6O5S3 |
| Mol. mass | 506.58 g/mol |
|
|
|
|
| |
|
Cefditoren is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.
Cefditoren is also marketed under the name Meiact.[1]
Contents |
Clinical use [edit]
Main article: Cephalosporin
Indications [edit]
Cefditoren is used to treat uncomplicated skin and skin structure infections, community-acquired pneumonia, acute bacterial exacerbation of chronic bronchitis (ABECB), pharyngitis, and tonsillitis.
Formulations [edit]
Cefditoren is available as 200 and 400 mg tablets. It can be formulated as the prodrug cefditoren pivoxil.
References [edit]
External links [edit]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||